CTIS.eu › Cities › Belgium › Aalst
Aalst
Belgium
115 total trials
44 recruiting
2022-502375-37-00
6
2023-04-16
heartburn
2024-511755-18-00
5
2022-12-23
Invasive Candidiasis/ Candidemia
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
2024-514714-12-00
10
2022-11-11
Metastatic Pancreatic Ductal Adenocarcinoma
2023-506981-30-00
4
2022-05-25
Chronic kidney disease in type 2 diabetes mellitus
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
2024-511140-37-00
4
2021-02-12
OligoRecurrent prostate cancer
2022-502031-20-00
10
2020-12-17
Non-squamous non-small cell lung cancer (NSCLC)
2022-501972-25-00
5
2020-04-06
Locally Advanced Cervical Cancer
2023-508364-29-00
5
2019-11-22
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
2022-502858-14-00
5
2019-09-05
Hypertrophic cardiomyopathy
2022-501970-20-01
5
2019-06-07
Cis-eligible Muscle-invasive bladder cancer.
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
2022-502747-35-00
5
2019-02-18
Newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ova
2023-510189-28-00
6
2018-05-15
Rheumatoid Arthritis
2023-510296-56-00
5
2018-03-26
Advanced Urothelial Cancer
2024-518736-37-00
6
2018-01-12
Risk of stroke by Atrial Fibrillation
2022-501353-37-00
5
Reversal of anticoagulation effect in patients on a FXa inhibitor (api
2023-506487-13-00
5
Hormone receptor-positive, her2-negative advanced/metastatic breast ca
Showing 97–115 of 115 trials